1 way to protect your smile See more of our coverage in your search results
Most of the studies reviewed have a high risk of bias (e.g., failure to blind, failure to report randomization procedures, and failure to use a placebo or sham control group) and small sample sizes
PT-141, also known as Bremelanotide, became the first FDA-approved treatment specifically targeting hypoactive sexual desire disorder in women, validating decades of research into melanocortin-based sexual function modulation
Shares of Zealand Pharma dropped by a record 35% the day after the announcement, while Roche fell around 3%
Anxiety disorders can continue even when there is no immediate danger
If the creatinine level is not within range, providers are alerted and further testing may be necessary